ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,099.96
1.02%
US Tech 100
17,244.80
1.57%
다우존스 지수
38,239.66
0.40%
Bitcoin
63,302.86
-0.68%
Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. bluebird bio Inc (BLUE)

  7. bluebird bio Inc (BLUE) 뉴스

BLUE bluebird bio Inc

0.9399
0.0274 (3.00%)
27 4월(4) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
bluebird bio Inc BLUE 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
0.0274 3.00% 0.9399 08:40:57
개장가 저가 고가 종가 전일 종가
0.9102 0.893 0.9458 0.9228 0.9125
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
27/04/202405:05BWbluebird bio Announces Receipt of Expected Notice from..
26/04/202418:45PRNUSBLUE LAWSUIT ALERT: The Gross Law Firm Notifies bluebird..
19/04/202418:45PRNUSbluebird bio, Inc. Sued for Securities Law Violations -..
16/04/202418:45PRNUSClass Action Filed Against bluebird bio, Inc. (BLUE) Seeking..
12/04/202418:45PRNUSShareholders that lost money on bluebird bio, Inc.(BLUE)..
11/04/202421:00BWbluebird bio Reports Inducement Grants Under Nasdaq Listing..
09/04/202418:45PRNUSbluebird bio, Inc. Sued for Securities Law Violations -..
05/04/202418:45PRNUSShareholders that lost money on bluebird bio, Inc.(BLUE)..
26/03/202420:01BWbluebird bio Reports Fourth Quarter and 2023 Annual Results..
26/03/202405:05BWbluebird bio to Host Fourth Quarter and 2023 Annual Results..
18/03/202421:00BWbluebird bio Secures up to $175 Million Debt Financing with..
11/03/202421:00BWbluebird bio Announces First Outcomes-Based Agreement with..
06/03/202407:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202407:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202407:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202407:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202407:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/02/202403:54EDGAR2Form SC 13G - Statement of acquisition of beneficial..
07/02/202406:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/02/202406:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/02/202406:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/01/202406:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/01/202406:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/01/202406:35EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/01/202422:03EDGAR2Form 8-K - Current report
08/01/202422:00BWbluebird bio Provides Update on Commercial Launch Progress,..
04/01/202422:00EDGAR2Form 8-K - Current report
02/01/202422:00BWbluebird bio to Present at the 42nd Annual J.P. Morgan..
21/12/202307:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
20/12/202321:42EDGAR2Form 8-K - Current report
20/12/202311:41BWbluebird bio, Inc. Announces Pricing of $125 Million Public..
19/12/202320:10IHMARKETNEWSGoogle $700M Antitrust Settlement, TSMC Chairman Retirement,..
19/12/202307:07EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
19/12/202306:48EDGAR2Form 8-K - Current report
19/12/202306:01BWbluebird bio, Inc. Announces Proposed Public Offering of..
14/12/202321:30EDGAR2Form 8-K - Current report
11/12/202322:06EDGAR2Form 8-K - Current report
11/12/202302:02BWLong-Term Data Presented at ASH Support beti-cel as a..
10/12/202301:31BWLong-term Follow-up Data From bluebird’s Gene Therapy..
09/12/202306:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/12/202306:11DJNBluebird Bio Shares Slide 41% on Black-Box Label, Higher..
09/12/202303:01BWbluebird bio Details Plans for the Commercial Launch of..
09/12/202302:35BWbluebird bio Announces FDA Approval of LYFGENIA™..
09/12/202302:03DJNBluebird Bio Gets FDA OK of Lyfgenia Gene Therapy in..
07/11/202321:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202321:01EDGAR2Form 8-K - Current report
07/11/202321:00BWbluebird bio Reports Third Quarter 2023 Financial Results..
04/11/202305:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/11/202305:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/11/202322:37BWbluebird bio to Present New and Updated Data from Gene..

최근 히스토리

NASDAQ
BLUE
bluebird bio
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유